Compatibility and System Requirements | EndNote – Experience the benefits of the legendary office suite

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Mail Merge Expert. Now you can address envelopes and labels more quickly and easily. The Mail Merge Expert makes it simple to associate a data source, such as an address book or a spreadsheet, with form documents, including letters, labels, and envelopes.

Let the Mail Merge Expert guide you through the process—step by step. Keystroke Menu. The Keystroke Menu helps to quickly access settings and commands.

Simply type the first few letters of the feature you’re looking for and WordPerfect will present a series of available matches. Make It Fit. Avoid spending time adjusting margins and fonts or cutting out text.

File Format Support. Famous for its unrivalled compatibility, WordPerfect Office enables users to work with more files than ever. Easily open, edit, and share files with support for more than 60 formats. Save to Multiple Formats. Experience multitasking at its best!

Publish to HTML. It provides more publishing options, such as relative font sizing and the ability to publish footnotes. PDF Support. You asked for it, and now we’ve got it. The PDF Form feature helps you to create fillable forms for collecting information interactively. Easily add a range of form controls, including text fields, check boxes, drop-down lists, and more.

Changing the form’s appearance—font, style, and color—is easy to do. PDF Export. With suite-wide PDF publishing options, WordPerfect Office ensures that you can share your documents, charts, and presentations with anyone.

You can adjust PDF file size and print resolution to suit a variety of destination platforms, such as web, email, and print. PDF Security and Archiving. This office suite also supports PDF password protection, which enables users to restrict who can view, copy, print, or edit PDFs.

Customization and support. Desktop client software for Windows and IOS. Also available as a web application either used separately or synchronised to desktop. Export references from compatible databases into your EndNote Library. Can host full text. Combine with word processor to automatically insert and format citations and bibliography.

Most scholarly databases interact directly with EndNote to export into your Library. Manually create records if import option not available e. Best with records for traditional formats articles, books, etc. PDFs, images and other file types can also be stored in the records. Yes, desktop allows you to share your entire library.

Online allows you to share groups of references. We can only supply the desktop client to current students and staff; if you leave Swinburne the online version changes to a free limited space account after two years.

Zotero can tell when you are looking at an item and shows an icon for it in the browser’s URL bar. Click the icon to add the item to your Zotero references. Yes, if you choose to share them. You can set up individual and group profiles and share records.

You can create a list of Works Cited for Google Docs. Yes, if you choose to back up or sync your Zotero library. A small amount of storage is free. Yes, a mobile site through Zotero.

Export references from compatible databases. Mendeley will also retrieve metadata for pdfs that are brought in. Very simple using the Mendeley browser plugin. However, the import doesn’t work with as many databases as other products. Click the button below to fill out our form if you have any questions or issues with using EndNote to manage your references. Skip to search Skip to content. There are two versions of EndNote available: EndNote online — recommended for coursework students EndNote for desktop Windows and Mac — recommended for researchers.

EndNote online Members of the Swinburne community can sign up for a free EndNote online account for an easy way to store and organise your references and create bibliographies for your assignments.

Register now. Register here. Need help? Watch now EndNote online video tutorials. Let us help you make the most of EndNote Training Options. Video Tutorials Watch our library of brief video tutorials. Self-Guided Learning Enroll for in-depth, self-guided courses, available when you are. Live Training Sign up for live training webinars. LibGuides Find highly-detailed articles, guides, and special resources for librarians.

Recorded Webinars Watch previously recorded webinars. New to EndNote Desktop? Here are some materials to help you get started. EndNote 20 Windows guide: library overview This quick reference guide provides a quick tour of the refreshed library window introduced in EndNote The clinical characteristics of Coronavirus disease COVID include respiratory symptoms, fever, cough, dyspnea, and pneumonia.

In the absence of any established pharmacological agents, supportive care remains the cornerstone of clinical management for COVID 3.

An emergency use authorization EUA for convalescent plasma was announced on August 23, 6. An EUA was issued for baricitinib on November 19, for use, in combination with remdesivir 8 , and for casirivimab and imdevimab on November 21 9. Due to the urgency of the situation, a number of already approved and marketed drugs are being tested for repurposing, including Favipiravir Favipiravir, also known as T, a purine nucleic acid analog, is one of the antiviral candidates considered in several clinical trials.

It is a chemical used experimentally and was created by the Japanese company Toyama, a subsidiary of Fuji Film, as reported initially by Furuta in In , it was approved in Japan as a backup choice for resistant influenza infection and since then have been approved in several countries and is indicated for the treatment of patients with mild to moderate COVID disease As of the 12th October , there are 37 studies registered in the ClinicalTrials.

Even though multiple articles about Favipiravir are readily available for download online, including some systematic reviews and meta-analyses conducted on only two RCTs at this time 17 , 18 , 19 , 20 , 21 , the scientific community may find it challenging to get an overview regarding the safety and efficacy of this drug. Therefore, we aim to provide this systematic review and meta-analysis of Favipiravir. To do so, we assess all available completed clinical trials till December 3.

Also, we published this protocol in the BMJ Open journal 3. All clinical trials study design which addressed the safety and efficacy of Favipiravir intervention in comparison to other control groups comparison for treatment of patients with confirmed infection with SARS-CoV2 population were included.

There were no restrictions concerning gender, age, ethnicity, blinding, follow-up, or publication status. All publications in English and Farsi were included.

It should be noted that some of the outcomes mentioned in the protocol were not analyzed due to the lack of sufficient data in the final included articles. The data containing at least one Favipiravir-related outcome or side effects were considered sufficient. Articles with unavailable full text in English or Farsi languages or whose full text is not accessible were excluded from the study.

The studies with insufficient or incomplete data were not being incorporated. We also searched two preprint databases including MedRxiv and Research Square and, the reference lists of all included studies, reviews, and clinical trial registries, for an ongoing clinical trial.

In addition, we created an alarm on Google Scholar and included new related articles. Once the records have been imported to EndNote X7 software and all duplicates have been removed, two reviewers SH and BA manually and independently screened titles, abstracts, and full-texts of included studies based on predefined eligibility criteria to identify studies concerning the safety and efficacy of Favipiravir among patients with COVID All potentials discrepancies were resolved upon consultation with a third reviewer MA-Z.

Two reviewers SH and BA independently extracted data from included studies, using a pre- piloted data extraction form. The data extraction form includes the following items; authors name, year of the publication, study design, study sample, country of origin, mean age of participants, gender, the severity of diseases, comorbidities, type of intervention and dose, control group, follow up, randomization, blinding, allocation concealment, primary and secondary outcomes, and adverse events 3 , All potentials discrepancies were resolved by consultation with a third reviewer RM.

Two reviewers MF and FH independently assessed the risk of bias among the included studies. We assessed the risk of bias of the included studies using Cochrane Collaboration criteria, including seven items of selection bias random sequence generation and allocation concealment , performance bias, detection bias, attrition bias, reporting bias, and other forms of bias 3 , Any discrepancies were resolved upon consultation with a third reviewer MA-Z.

CMA software has the ability to combine different indices and to combine the effect of sample size and the difference of the index being compared We used the I 2 statistics and Cochran test with significantly less than 0.

In cases where there was heterogeneity, we performed the random-effect model. We also used a subgroup analysis based on follow up days for clinical improvement and viral clearance. One-leave-out sensitivity analysis were conducted for all outcomes based on Cochrane recommendation.

We identified a total of records after searching the databases. After the removal of duplicate records, the title and abstracts of records were screened. Eight hundred eighty-five records were excluded after title and abstracts screening, and 24 records were assessed for full-text screening. A total of 15 records were excluded based on eligibility criteria. Finally, nine studies were included in our meta-analysis 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 Fig. Nine studies encompassing patients were included.

According to the geographical area, four studies were conducted in China Only one study was nonrandomized. The minimum follow-up time was 10 days, and the maximum was 30 days. The doses of Favipiravir and control drugs in each study were different. All studies registered in clinical trial registries. The summary characteristics of the included studies have been summarized in Table 1. Eight Six studies None of the studies reported acceptable blinding for participants and personnel.

Only one study The risk of bias summary and risk of bias graph is reported in Supplementary file 2 and 3. Among the included studies, six studies assessed clinical improvement during 14 days after hospitalization, and five studies were assessed during seven days after hospitalization. The meta-analysis of clinical improvement of Favipiravir on COVID patients black circle: individual studies; orange diamond: overall of subgroups; red diamond: overall of all included studies.

The meta-analysis of viral clearance of Favipiravir on COVID patients orange diamond: summery of sub groups; red diamond: summery of total. The meta-analysis of requiring supplemental oxygen therapy of Favipiravir on COVID patients red diamond: summery of total. Almost all adverse events of Favipiravir were mild to moderate and in an equal or lower rate compared to the control groups.

The most prevalent adverse events included nausea, vomiting, diarrhea, chest pain as well as increase in serum liver transaminase and uric acid levels.

The results of sensitivity analysis did not show any difference in all outcomes and confirmed the previous results. The number of infected cases, as well as the mortality rate associated with the virus, has astronomically raised around the world. The main challenge of COVID is the lack of approved pharmacotherapy and vaccination, as well as the absence of evidence for reliable treatment options Although various agents are undergoing clinical trials, the urgency of the situation has made scientists repurpose the antiviral agents.

Favipiravir, as a ribonucleotide analog and selective inhibitor of the viral RNA polymerase enzyme, can cause widespread antiviral activity against RNA-carrying viruses, thereby preventing replication and transcription of the viral genome It has been approved for the treatment of new influenza viruses in Japan and China. It has also been shown to be effective against Ebola and RNA viruses caused by viral hemorrhagic fever Moreover, this drug revealed controversial results in different clinical trials conducted on COVID Our meta-analysis was carried out on nine eligible studies with patients.

The obtained results demonstrated the clinical improvement after seven and 14 days of hospitalization was more remarkable in patients taking Favipiravir than those receiving other drugs.

 
 

 

Endnote x7 open office free

 

EndNote X9 lets you categorize the records on various sections and groups so that any book or article of your interest. It has got Quick Search function which will let you to locate the right item with a keyword. EndNote X9 enables you to open an existing library or create the new one to which you can add and change the items. For creating new entries you are required to input several details about it like Reference Type where you can select various different options like Book, Web Page, Thesis, Report, Manuscript, Blog and Computer Program etc.

All in all EndNote X9 is a very handy application which will allow you to keep track of your source materials. This is complete offline installer and standalone setup for EndNote X9. This would be compatible with both 32 bit and 64 bit windows. Black out sensitive or confidential information and ensure that text cannot be retrieved or revealed. This versatile feature can also search a document for words and phrases to hide, and automatically apply redaction.

Redacted files can be saved to. Adding Bates numbering to critical files is standard practice in many fields—including law and medicine—and can be tedious and time-consuming. Save precious time with this tool by easily inserting Bates numbers in WordPerfect documents. Every page in a document or a folder of documents is assigned a unique, incremental number for quick identification.

WordPerfect eBook publisher enables relative font and graphic sizing, and automatic conversion of footnotes to cross-linked endnotes. Search and Find and Replace in Quattro Pro. Macro Manager. Put your macros to work as soon as you need them with the Macro Manager.

This dialog box presents all WordPerfect macros in a single, convenient location. Now you can view each macro’s properties, add descriptions, and run or edit the macros. Find it With Favorites.

Keeping track of several documents on your desktop at the same time can be a cumbersome task. Not anymore! Simply use the Favorites feature to instantly mark all your relevant documents. Next, click on your toolbar to simultaneously open your set of most frequently used documents. Mail Merge Expert. Now you can address envelopes and labels more quickly and easily. The Mail Merge Expert makes it simple to associate a data source, such as an address book or a spreadsheet, with form documents, including letters, labels, and envelopes.

Let the Mail Merge Expert guide you through the process—step by step. Keystroke Menu. The Keystroke Menu helps to quickly access settings and commands. Simply type the first few letters of the feature you’re looking for and WordPerfect will present a series of available matches. Make It Fit. Avoid spending time adjusting margins and fonts or cutting out text. File Format Support. Famous for its unrivalled compatibility, WordPerfect Office enables users to work with more files than ever.

Easily open, edit, and share files with support for more than 60 formats. Save to Multiple Formats. Experience multitasking at its best! Publish to HTML. It provides more publishing options, such as relative font sizing and the ability to publish footnotes.

PDF Support. You asked for it, and now we’ve got it. The PDF Form feature helps you to create fillable forms for collecting information interactively. Easily add a range of form controls, including text fields, check boxes, drop-down lists, and more. Changing the form’s appearance—font, style, and color—is easy to do. PDF Export. With suite-wide PDF publishing options, WordPerfect Office ensures that you can share your documents, charts, and presentations with anyone.

You can adjust PDF file size and print resolution to suit a variety of destination platforms, such as web, email, and print. PDF Security and Archiving. This office suite also supports PDF password protection, which enables users to restrict who can view, copy, print, or edit PDFs. Customization and support. Function Key Template. Use a few simple clicks to get the exact template you need—either from the latest version of WordPerfect or from your customized keystrokes.

Web Services Integration. Gather up-to-the-second data from the Web and then automatically update a document with that information whenever you open it. For example, create a report with updated stock prices, send out a real-estate brochure that pulls in new MLS listings, or publish daily weather reports. Bring the power of the Web to all your documents with WordPerfect Office. Legal Toolbar. WordPerfect Office has a set of built-in tools designed specifically for legal professionals.

Easily create and format pleading papers, generate indexes and tables of content—even create a Table of Authorities. File previewing and viewing. Open Footnotes and Endnotes for Editing in a Click.